We are delighted to announce early bird registration for FIGO Cape Town 2025 is now open! Our world-class Congress will take ...

"The results present that FIGO AUB System 2 (PALM-COEIN) is widely recognised globally, but many trainees lack formal ...

The preconception period is a critical "window of opportunity" to address health risks and establish healthier habits to prevent maternal and foetal morbidity and mortality. Prior to conception, ...

A groundbreaking standardised protocol for managing complex caesarean sections has been introduced by the FIGO Committee on Childbirth and Postpartum Haemorrhage. Published in the International ...

In 2022, the World Health Organization (WHO) updated its Abortion care guideline, widening its scope to include evidence-based recommendations in legal, regulatory, policy and service-delivery aspects ...

FIGO regularly issues statements and joint statements.

The Committee on Menstrual Disorders and Related Health Impacts focuses on the set of symptoms described as non-gestational abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).

The project ended in India and Sri Lanka in December 2018, Nepal in June 2019, Kenya in September 2019, Tanzania in March 2020 and in Bangladesh in October 2020. Across 48 Referral Hospitals, the ...

FIGO Divisions and Committees bring together experts from our member societies with other health care professionals focusing on specialist areas of obstetrics and gynaecology to encourage global ...

Worldwide, the growing use of contraceptive methods has led to a reduction in maternal and infant mortality, improvements in socio-economic conditions and increased schooling for girls and women.

FIGO regards reproductive choice, including access to safe abortion services, as a basic and non-negotiable tool for ensuring the human rights of every woman, not just in one region or country, but ...